Condition
Complication of Renal Dialysis
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (2)
Trial Status
Completed2
Unknown1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02513303Phase 3CompletedPrimary
Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes
NCT05425056Phase 3CompletedPrimary
A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery
NCT03820765UnknownPrimary
Cessation of Dialysis Treatment in Reinbek and Geesthacht
NCT02764736Not ApplicableWithdrawnPrimary
Atorvastatin Reduces Chronic Inflammation and aVerage Epogen Dose (ARChIVED)
Showing all 4 trials